General Electric to buy BK Medical in $1.45B deal

  • General Electric (NYSE:GE) has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for $1.45B in cash.
  • The deal looks to help in GE Healthcare's expansion beyond diagnostics into surgical and therapeutic interventions.
  • GE Healthcare, which is the healthcare business of GE, expects BK Medical to deliver rapid revenue growth as well as margin expansion and free cash flow growth.
  • The company expects high-single-digit return on invested capital by year five.
  • "Adding the fast-growing and relatively new field of real-time surgical visualization to GE's pre- and post-operative Ultrasound capabilities will create an end-to-end offering through the full continuum of care-from diagnosis through therapy and beyond," GE Healthcare Ultrasound President and CEO Roland Rott said.
  • The deal is expected to close in 2022.

    Over the current book year the company from Boston could achieve a revenue around 77.08 billion USD (consensus estimates). This is slightly lower than 2021's revenue of 79.62 billion USD.

    Historical revenues and results General Electric plus estimates 2021

    aandelenanalyses

    The analysts expect for 2021 a net profit of 2.25 billion USD. For this year the consensus of the result per share is a profit of 2.04 USD. The price/earnings-ratio therefore equals a very high 51.87.

    Per share the analysts anticipate on a dividend of 32 cents per share. Thus the dividend yield equals 0.3 percent. The average dividend yield of the diversified companies equals an attractive1.97 percent.

    General Electric 's market capitalization is based on the number of outstanding shares around 115.59 billion USD. 108

    On Friday the stock closed at 105.82 USD.

    Historical stock prices General Electric past 10 years

    stock analysis generalelectric

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.